North America Wearable Injectors Market Size & Outlook
North America wearable injectors market, 2018-2030 (US$M)
Related Markets
North America wearable injectors market highlights
- The North America wearable injectors market generated a revenue of USD 2,918.4 million in 2023.
- The market is expected to grow at a CAGR of 15.3% from 2024 to 2030.
- In terms of segment, on-body was the largest revenue generating type in 2023.
- Off-body is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 2,918.4 million |
| Market revenue in 2030 | USD 7,885.4 million |
| Growth rate | 15.3% (CAGR from 2023 to 2030) |
| Largest segment | On-body |
| Fastest growing segment | Off-body |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-body, Off-body |
| Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
Other key industry trends
- In terms of revenue, North America region accounted for 33.2% of the global wearable injectors market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,545.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wearable Injectors Market Scope
Wearable Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America wearable injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 55.52% in 2023. Horizon Databook has segmented the North America wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the wearable injectors market in 2022 and is expected to maintain its position over the forecast period. Major factors contributing to the growth of this region include high penetration of diagnostic, therapeutic, and medical devices such as wearable injectors for disease management.
Increase in burden of chronic diseases and rise in geriatric population are also driving the market. For instance, according to the U.S. Census Bureau, in 2020, about 16.9% of the population in the U.S. was aged 65 and above. In addition, according to the American Diabetes Association, in 2019, 11.3% or 37.3 million Americans were living with diabetes.
Moreover, the launch and approval of advanced, next-generation devices in the U.S. and Canada, as well as technological advancements in wearable injectors, are likely to drive the market. Some of the major companies operating in North America are BD, Johnson & Johnson Services, Inc., Unilife Corporation, Enable Injections, and West Pharmaceutical Services, Inc., among others.
Reasons to subscribe to North America wearable injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America wearable injectors market databook
-
Our clientele includes a mix of wearable injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America wearable injectors market , including forecasts for subscribers. This continent databook contains high-level insights into North America wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America wearable injectors market size, by country, 2018-2030 (US$M)
North America Wearable Injectors Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
